United Therapeutics Corp. (UTHR)
568.58
-7.21
(-1.25%)
USD |
NASDAQ |
May 15, 16:00
569.05
+0.47
(+0.08%)
Pre-Market: 20:00
United Therapeutics Market Cap : 24.13B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| MannKind Corp. | 954.66M |
| Catalyst Pharmaceuticals, Inc. | 3.816B |
| Insmed, Inc. | 23.66B |
| Amgen, Inc. | 176.21B |
| Ionis Pharmaceuticals, Inc. | 12.27B |
Market Cap Related Metrics
| PE Ratio | 20.98 |
| PS Ratio | 8.525 |
| PEG Ratio | 2.581 |
| Price to Book Value | 4.090 |
| Price to Free Cash Flow | 26.72 |
| Price | 568.58 |
| Earnings Yield | 4.77% |
| PEGY Ratio | 2.581 |
| Operating PE Ratio | 18.52 |
| Normalized PE Ratio | 22.04 |